- Home
- ACET vs OPHC Comparison
ACET vs OPHC Comparison
Compare ACET & OPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- OPHC
- Stock Information
- Founded
- ACET 1947
- OPHC 2000
- Country
- ACET United States
- OPHC United States
- Employees
- ACET N/A
- OPHC N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- OPHC Major Banks
- Sector
- ACET Health Care
- OPHC Finance
- Exchange
- ACET Nasdaq
- OPHC Nasdaq
- Market Cap
- ACET 44.4M
- OPHC 43.1M
- IPO Year
- ACET N/A
- OPHC N/A
- Fundamental
- Price
- ACET $0.59
- OPHC $4.25
- Analyst Decision
- ACET Buy
- OPHC Hold
- Analyst Count
- ACET 6
- OPHC 1
- Target Price
- ACET $6.00
- OPHC $5.25
- AVG Volume (30 Days)
- ACET 509.0K
- OPHC 20.4K
- Earning Date
- ACET 05-13-2025
- OPHC 05-12-2025
- Dividend Yield
- ACET N/A
- OPHC N/A
- EPS Growth
- ACET N/A
- OPHC 53.23
- EPS
- ACET N/A
- OPHC 1.33
- Revenue
- ACET N/A
- OPHC $37,091,000.00
- Revenue This Year
- ACET N/A
- OPHC N/A
- Revenue Next Year
- ACET N/A
- OPHC N/A
- P/E Ratio
- ACET N/A
- OPHC $3.18
- Revenue Growth
- ACET N/A
- OPHC 60.44
- 52 Week Low
- ACET $0.45
- OPHC $3.53
- 52 Week High
- ACET $1.87
- OPHC $5.90
- Technical
- Relative Strength Index (RSI)
- ACET 42.27
- OPHC 58.71
- Support Level
- ACET $0.51
- OPHC $3.95
- Resistance Level
- ACET $0.62
- OPHC $3.98
- Average True Range (ATR)
- ACET 0.06
- OPHC 0.15
- MACD
- ACET 0.01
- OPHC 0.06
- Stochastic Oscillator
- ACET 63.38
- OPHC 100.00
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About OPHC OptimumBank Holdings Inc.
OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides a range of community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal account, money market deposit accounts, debit cards, and automated teller machines.